Marc Since
Impact in
- Drug Discovery top 10%
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
Papers in
- Pharmacology 10
- Cholinesterase and Neurodegenerative Diseases 9
-
- Drug Solubulity and Delivery Systems 4
- Co-authors
- Aurélie Malzert‐Fréon (17 shared papers)Sophie Corvaisier (18 shared papers)Christophe Rochais (15 shared papers)Patrick Dallemagne (16 shared papers)Cédric Lecoutey (10 shared papers)Thomas Fréret (9 shared papers)Loïc Le Pluart (3 shared papers)Michel Boulouard (7 shared papers)
- Journals
- European Journal of Medicinal Chemistry (12 papers)ChemMedChem (3 papers)International Journal of Pharmaceutics (3 papers)ACS Chemical Neuroscience (2 papers)ACS Medicinal Chemistry Letters (2 papers)
- Partner nations
- FranceUnited KingdomItaly
In The Last Decade
Marc Since
37 papers receiving 717 citations
Peers
Comparison fields: 5 of 57
- Drug Discovery 6
- Pharmaceutical Science 135
- Pharmacology 138
- Biomaterials 98
- Organic Chemistry 188
Countries citing papers authored by Marc Since
This map shows the geographic impact of Marc Since's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Since with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Since more than expected).
Fields of papers citing papers by Marc Since
This network shows the impact of papers produced by Marc Since. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Since. The network helps show where Marc Since may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc Since, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 106 | |
| 2 | 2020 | 70 | |
| 3 | 2021 | 59 | |
| 4 | 2015 | 55 | |
| 5 | The design of donecopride, a dual 5-HT4R agonist/AChE inhibitor with potential interest for AD treatment | 2014 | 34 |
| 6 | 2018 | 34 | |
| 7 | 2020 | 30 | |
| 8 | 2013 | 27 | |
| 9 | 2019 | 27 | |
| 10 | 2024 | 27 | |
| 11 | 2016 | 21 | |
| 12 | 2009 | 20 | |
| 13 | 2020 | 20 | |
| 14 | 2020 | 19 | |
| 15 | 2022 | 19 | |
| 16 | 2019 | 16 | |
| 17 | 2021 | 16 | |
| 18 | 2016 | 15 | |
| 19 | 2020 | 14 | |
| 20 | 2017 | 11 |
About Marc Since
Marc Since is a scholar working on Pharmacology, Pharmaceutical Science, Organic Chemistry, Physiology and Biomaterials, having authored 44 papers that have together received 733 indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (9 papers), Alzheimer's disease research and treatments (7 papers), Synthesis and biological activity (7 papers), Research on Leishmaniasis Studies (5 papers), Drug Solubulity and Delivery Systems (4 papers), Trypanosoma species research and implications (4 papers), Nanoparticle-Based Drug Delivery (3 papers) and Malaria Research and Control (2 papers). The work is most often cited by research in Drug Discovery (6 citations), Pharmaceutical Science (135 citations), Pharmacology (138 citations), Biomaterials (98 citations) and Organic Chemistry (188 citations). Marc Since has collaborated with scholars based in France, United Kingdom and Italy. Frequent co-authors include Aurélie Malzert‐Fréon, Sophie Corvaisier, Christophe Rochais, Patrick Dallemagne, Cédric Lecoutey, Thomas Fréret, Loïc Le Pluart, Michel Boulouard, Sylvie Claeysen and Audrey Davis. Their work appears in journals such as European Journal of Medicinal Chemistry, ChemMedChem, International Journal of Pharmaceutics, ACS Chemical Neuroscience and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.